Treatment and Outcomes of Precocious Puberty: An Update
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Precocious puberty is a common problem affecting up to 29 per 100,000 girls per year. The earliest identified neuroendocrine change in early puberty thus far is increased kisspeptin secretion from the arcuate nucleus and the anteroventral paraventricular nucleus of the hypothalamus. The regulation of kisspeptin secretion is not well understood, but neurokinin B and dynorphin provide autocrine regulation. The etiologies of precocious puberty may be subdivided into GnRH-dependent and GnRH-independent causes. GnRH-dependent precocious puberty, often called central precocious puberty (CPP), is usually treated with GnRH analogs. Newer developments in the treatment of CPP include expanded data on the safety and efficacy of the subdermal histrelin implant, which is useful for long-term treatment, although removal may be difficult in some cases. Preliminary data suggest that the implant may be left in place for up to 2 years without loss of biochemical suppression. In the last 2 years, more data have been published concerning extended-release leuprolide acetate injections that indicate that the 11.25-mg dose may not provide full biochemical suppression but may clinically suppress signs of puberty, including the accelerated growth velocity and advanced skeletal maturation seen in CPP. Treatment options for familial male-limited precocious puberty and McCune-Albright syndrome are expanding as well, although data are preliminary. Long-term outcome studies of CPP indicate overall good menstrual and reproductive function, but the prevalence of polycystic ovary syndrome may be higher than in the general population. Remarkably few studies have evaluated the behavioral and psychological outcomes of precocious puberty, in contrast to early normal maturation. Additional outcome studies of endocrine, metabolic, and psychological effects of CPP are clearly needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Enlarged testis corresponding with the pubertal stage suggests GDPP, while pre-pubertal testis indicates GIPP.”
From Congenital adrenal hyperplasia complicated by gonadotropin-dependent precocious puberty (2024) · cites this paper as [16]
In the citing paper
“Pubertal testis smaller than expected with pubic hair growth means apparent LH excess (hCG-secreting tumour or testotoxicosis) or GDPP superimposed on GIPP.16”
From Congenital adrenal hyperplasia complicated by gonadotropin-dependent precocious puberty (2024) · cites this paper as [16]
In the citing paper
“The most important pointer to the source of androgen production in a boy with precocious puberty is testicular volume.”
From Congenital adrenal hyperplasia complicated by gonadotropin-dependent precocious puberty (2024) · cites this paper as [16]
Citations
Cites
Variations in pattern of pubertal changes in girls
Marshall, W. A., & Tanner, J. M. (1969) · Archives of Disease in Childhood · doi:10.1136/adc.44.235.291 · Cited by 5,963 · cited 1×
“The degree of pubertal maturation is usually described using the Tanner stages of sexual maturation (4) (Table 1).”
MethodHerman-Giddens, M. E., Slora, E. J., Wasserman, R. C., Bourdony, C. J., Bhapkar, M. V., Koch, G. G., & Hasemeier, C. M. (1997) · PEDIATRICS · doi:10.1542/peds.99.4.505 · Cited by 1,709
Topaloglu, A. K., Reimann, F., Guclu, M., Yalin, A. S., Kotan, L. D., Porter, K. M., Serin, A., Mungan, N. O., Cook, J. R., Ozbek, M. N., et al. (2009) · Nature Genetics · doi:10.1038/ng.306 · Cited by 961 · cited 1×
“Although mutations of neurokinin b and dynorphin could theoretically cause early pubertal development, such mutations have not yet been identified (12).”
BackgroundConsensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children
Carel, J.-C., Eugster, E. A., Rogol, A., Ghizzoni, L., Palmert, M. R., & on behalf of the members of the ESPE-LWPES GnRH Analogs Consensus Conference Group (2009) · Pediatrics · doi:10.1542/peds.2008-1783 · Cited by 817 · cited 2×
“in those with CPP (30) than in those with normal puberty,”
BackgroundEarlier Onset of Puberty in Girls: Relation to Increased Body Mass Index and Race
Kaplowitz, P. B., Slora, E. J., Wasserman, R. C., Pedlow, S. E., & Herman-Giddens, M. E. (2001) · Pediatrics · doi:10.1542/peds.108.2.347 · Cited by 751
Wakabayashi, Y., Nakada, T., Murata, K., Ohkura, S., Mogi, K., Navarro, V. M., Clifton, D. K., Mori, Y., Tsukamura, H., Maeda, K.-I., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5848-09.2010 · Cited by 597 · cited 5×
“org J Clin Endocrinol Metab, June 2013, 98(6):2198–2207 doi: 10.”
BackgroundInfluentialA GPR54 -Activating Mutation in a Patient with Central Precocious Puberty
Teles, M. G., Bianco, S. D. C., Brito, V. N., Trarbach, E. B., Kuohung, W., Xu, S., Seminara, S. B., Mendonca, B. B., Kaiser, U. B., & Latronico, A. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073443 · Cited by 572 · cited 1×
“in individuals with precocious puberty (10, 11).”
Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index
Rosenfield, R. L., Lipton, R. B., & Drum, M. L. (2009) · PEDIATRICS · doi:10.1542/peds.2008-0146 · Cited by 499
Herman-Giddens, M. E., Steffes, J., Harris, D., Slora, E., Hussey, M., Dowshen, S. A., Wasserman, R., Serwint, J. R., Smitherman, L., & Reiter, E. O. (2012) · PEDIATRICS · doi:10.1542/peds.2011-3291 · Cited by 392
Sørensen, K., Mouritsen, A., Aksglaede, L., Hagen, C. P., Mogensen, S. S., & Juul, A. (2012) · Hormone Research in Paediatrics · doi:10.1159/000336325 · Cited by 386
Cited by
Items 201–260 of 260
Stafford, D. E. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818872-9.00058-3 · Cited by 1
Ahn, J., Lee, Y. I., Gim, S., & Jeong, H. R. (2023) · Research Square · doi:10.21203/rs.3.rs-3108569/v1 · Cited by 1
Diagnostics étiologiques des pubertés précoces centrales
Coutant, R. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0521-4_8
Writers, A. M. (2015) · Drugs & Therapy Perspectives · doi:10.1007/s40267-015-0238-5
“Boys with CPP commonly present with bilateral testicular enlargement (volume of C4 mL), with girls generally presenting with both breast development and pubic hairs [3].”
BackgroundInfluentialGonadotropin-Dependent Precocious Puberty; Female and Male
Mul, D., Oostdijk, W., & Drop, S. L. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.03912-x
Devenir à moyen terme et à long terme des pubertés précoces centrales
Chao, C., & Christin‐Maître, S. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0521-4_10
Pubertad precoz y tumoración torácica: presentación de un caso
Reyna, M. N. L., Boggio, J. F., Lipa-Chancolla, R., Almache, O. N., Pinto, P., Robles, O. A. E., Chávez, E. M., Rojas-Gabulli, M. I., & Villar, C. D. Á. (2014) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2014.313.99
“La pubertad precoz es una de las condiciones más comunes encontradas en la práctica de la endocrinología pediátrica, afecta hasta 29 por cada 100 000 niñas al año (1) y se define como el desarrollo de caracteres sexuales antes de los 8 años en las niñas y de los 9 años en los varones.”
BackgroundUnravelling the link between insulin resistance and androgen excess
O’Reilly, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Clinical and Biological Diagnosis of Central Precocious Puberty
Léger, J., & Carel, J. (2015) · Springer eBooks · doi:10.1007/978-2-8178-0543-6_5
Etiological Diagnosis of Central Precocious Puberty
Coutant, R. (2015) · Springer eBooks · doi:10.1007/978-2-8178-0543-6_6
Mostafa, T. (2016) · Human Andrology · doi:10.1097/01.xha.0000473646.90564.16
A Patient with Septo-Optic Dysplasia Accompanying with Central Precocious Puberty
Tajima, S. M. T. (2015) · Journal of Clinical Case Reports · doi:10.4172/2165-7920.1000587
“It is thought there is little effect of treating girls aged over 8 years and with only central precocious puberty using GnRH analog for the purposes of increasing adult height [10].”
BackgroundPubertà precoce: diagnosi e terapia
Salerno, M., Rezzuto, M., & Alfano, S. (2016) · L Endocrinologo · doi:10.1007/s40619-016-0255-1
“Un ruolo nella regolazione della pubertà è stato attribuito anche alle cellule della neuroglia che, attraverso sinapsi dirette e tramite la produzione di fattori di crescita come il TGF-β e i peptidi EGF-like, stimolano lo sviluppo e l’attivazione dei neuroni GnRH secernenti [3].”
BackgroundInfluentialMale Puberty: What Is Normal and Abnormal?
Hansen, D. W., & Fuqua, J. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_5
Self-citationClinical Manifestations of Precocious Puberty and Associated Heritable Diseases: A Case Report
Milgraum, D. M., Allawh, R. M., Moon, A. T., & Allen, H. B. (2017) · Journal of Clinical & Experimental Dermatology Research · doi:10.4172/2155-9554.1000385
“In fact, the overall incidence of sexual precocity is estimated to be about 1:10,000 with a female-to-male ratio of nearly 10:1 [1].”
BackgroundAbodo, J., Agbré-Yacé, L., Hué, A., Soro-Coulibaly, T., Micondo, K. H., Sanogo, M., Danho, J., Ahoussi, J., & Lokrou, A. (2017) · Advances in Sexual Medicine · doi:10.4236/asm.2017.74013
Diagnosi e trattamento della pubertà precoce vera femminile
Cannavò, L., Corica, D., & Aversa, T. (2018) · L Endocrinologo · doi:10.1007/s40619-018-00481-1
11-year old boy with facial hair, acne and deepened voice
Ahmed, F., Zeve, D., Millington, K., & Rea, C. J. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-226600
Pienkowski, C., Cartault, A., & Bar, C. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75965-9.00005-2
Utilidad clínica de la medición de la hormona antimülleriana en niños
Tovar, J. D. L., Henao-Ochoa, C., Velásquez, J. M. A., & Campuzano‐Maya, G. (2017) · Medicina y Laboratorio · doi:10.36384/01232576.29
Ramos, C. D. O. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-06072020-163149 · Cited by 1
Shokri, E., Heidarianpour, A., & Razavi, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-560214/v1
Bhavan, S., Prasad, H. K., Sankaran, A., Govindram, V. P., Ravisekar, C. V., & Krishnamoorthy, N. (2021) · The New Indian Journal of OBGYN · doi:10.21276/obgyn.2021.8.1.12
Diagnosis and Treatment of Central Precocious Puberty
Choi, H. S., Kim, H.-S., & Chae, H. W. (2021) · Ewha Medical Journal · doi:10.12771/emj.2021.44.4.117
Diagnostic clinique et biologie des pubertés précoces centrales
Léger, J., & Carel, J. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0521-4_7
Alaniz, V., Huguelet, P. S., & Scott, S. (2013) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000439089.84809.94
Fudge, E. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_18 · Cited by 1
Selected Disorders of the Endocrine and Metabolic System
King, S. O., Mohiuddin, M. A., & Blondell, R. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_131-1
Selected Disorders of the Endocrine and Metabolic System
King, S. O., Mohiuddin, M. A., & Blondell, R. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-04414-9_131
Evaluation of Breast Lesions Using Mammography
Noor, M., John, A., Ali, A. S., Yousaf, A., & Bakhtawar, K. (2022) · Pakistan BioMedical Journal · doi:10.54393/pbmj.v5i6.545
Comparative RNA-seq analysis and ceRNA network of genistein-treated GT1-7 neurons
Xiong, J., Tian, Y., Ma, G., Ling, A., Shan, S., & Cheng, G. (2022) · Molecular & Cellular Toxicology · doi:10.1007/s13273-022-00279-1 · Cited by 1
“Hypothalamic GT1-7 neurons were widely used as a GnRH-expressing model to study the effects and mechanisms on GnRH secretions (Mahesh et al. 1999; Fuqua 2013).”
MethodPsychological aspects of precocious puberty child during the COVID-19 pandemic
Suciwiyati, N. I., Rochmah, N., Faizi, M., & Yofi, F. A. (2022) · Majalah Obstetri & Ginekologi · doi:10.20473/mog.v30i32022.139-145
“PP is responsible for early progression of secondary sexual characteristics, rapid bone maturation, final height reduction, inappropriate body appearance, and psychological behavioral abnormalities.(1,2)”
BackgroundStecchini, M. F. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-06022023-112309
Male Puberty: What Is Normal and Abnormal?
Hansen, D. W., & Fuqua, J. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_5
Self-citationMetabolomic Studies in Girls With Central and Peripheral Precocious Puberty
Balcı, A., Reçber, T., Nemutlu, E., Buluş, A. D., Kır, S., GÜMÜŞEL, B. K., & Erkekoğlu, P. (2023) · Fabad Journal of Pharmaceutical Sciences · doi:10.55262/fabadeczacilik.1344851
“Genetic factors, neurotransmitter, and hormone interactions might lead to ICPP (Kletter et al., 2015, Fuqua, 2013).”
BackgroundĐẶC ĐIỂM PHÁT TRIỂN THỂ CHẤT Ở TRẺ BỊ DẬY THÌ SỚM TRUNG ƯƠNG TẠI BỆNH VIỆN ĐA KHOA XANH PÔN
Nguyễn, Đ. T., & Ngô, T. T. H. (2024) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v536i1.8700 · Cited by 1
Transient synovitis associated with leuprolide depot (Lupron)
Steen, E. A., & Phillips, S. A. (2024) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-24-0031 · Cited by 1
“GnRHa therapies have been Food and Drug Administration (FDA) approved for use in CPP since 1993 (5 ).”
BackgroundInfluentialMännliche Pubertät: Was ist normal und was ist abnormal?
Hansen, D. W., & Fuqua, J. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_5
Self-citationMisra, M., & Radovick, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_25
Popczyńska, J., Raczyńska, A., Pacocha, N., Krzemień, O., Kosiec, K., Jędrychowski, J., Karpowicz, N., Kaszucka, J., Krzyżanowska, M., & Zgierska, M. (2024) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(44).2024.3072
Zhang, X., Cai, H., Zhang, C., Shen, X., & He, J. (2025) · Research Square · doi:10.21203/rs.3.rs-6208100/v1
Precocious Puberty Induced by Chronic Rhinosinusitis
Razaq, L., Mian, M. S. A., Faizan, M., Awais, M. A., Gilani, S. S., Uppal, R., Uppal, M. R., Saeed, U., Piracha, Z. Z., & Tariq, M. (2025) · The American Journal of Medical Sciences and Pharmaceutical Research · doi:10.37547/tajmspr/volume07issue06-05
130 Genders and Counting: On Scientific Fact and Trans Livability
Beischel, W. J. (2025) · Archives of Sexual Behavior · doi:10.1007/s10508-025-03222-2
“…women who have had facial feminization surgery to align their gender identity with their appearance, and cisgender children who were prescribed puberty blockers to more easily align their developmental timelines with their peers (Ashley & Ells, 2018; Fuqua, 2013; Michaelson et al., 2008).”
Argueta, A. S., Díaz, Q. C., Argueta, V. H., & Vásquez, M. A. S. (2025) · Oxford Medical Case Reports · doi:10.1093/omcr/omaf150
“Taken together, the diagnostic approach supports a diagnosis of idiopathic central precocious puberty, with environmental and psychosocial factors likely playing a significant role in its pathogenesis [7, 8].”
张, 佳. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.45470
Ayalew, H., Obianwuna, U. E., Wassie, T., Xu, C., Wang, J., Melaku, M., Wu, S., & Zhang, H. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105952
“In layer chickens, early the GIT impairment has been further linked to delayed onset of puberty, disrupt ovarian folliculo-genesis and ovulation, suboptimal reproductive performance, and shortened peak production duration (Han et al., 2016; Fuqua, 2013; Tan et al., 2021).”
Hypothalamic hamartoma presenting as central precocious puberty in a girl: a case report
Mohanty, S. R. (2025) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20253492
Huang, J., Wu, X., Zhao, R. Y., Huang, X., & Ren, X.-X. (2025) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2025.101073
Kim, Y., Eom, T.-K., Kim, Y., Rhee, J., & Kim, H. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211158
Lim, C. N., Yacoub, O. N. A., Mostafa, N. M., & Salem, A. H. (2026) · Pediatric Drugs · doi:10.1007/s40272-025-00733-2
“Precocious puberty is one of the more common conditions encountered in pediatric endocrinology practices [1].”
Lopes, A. E. M., de Brito, L. S., Sampaio, A. G., Lot, R. G., Brambilla, I. R., Dias, R. R. D. B., de Oliveira, J. A. C., Ribeiro, A. C. R., Iajarin, F. C. A., Rodart, I. F., et al. (2026) · Hormone and Metabolic Research · doi:10.1055/a-2771-0527
Ebo, C., Muthuvel, G., McCray, J., Penix, S., Hornung, L. N., Jones, N. Y., & Gutmark‐Little, I. (2026) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2026.115116
Ghiami, H., Arasteh, O., & Omidkhoda, N. (2026) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxag172
Bouvattier, C. M. (2026) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(26)42606-x
Banerjee, A. A., Bhanarkar, S. R., Kashikar, S., Keshwani, R., Walia, S., Kavya, D. R., Bombe, S., Pande, S. S., Modi, D. N., Pathak, B. R., et al. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121207
Magalhães, C., Esteves, I. M., Nunes, A. S., Gonçalves, C. P., Portela, M., Martins, S. A., Antunes, A., & Gomes, M. M. (2026) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2026.501917
Ilmer, S., & Salemi, P. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1951374
Cai, J., Zhang, L., Liu, W. V., Liu, Q., Lü, J., & Liu, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1981603
Triptorelin-stimulated gonadotropin concentrations for precocious puberty
Koh, E., & Kim, C. J. (2026) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2550394.197
“Contemporary clinical experience and the literature support a continuum of HPG-axis activation, with substantial overlap at first presentation [1,4-7].”
Prise en charge thérapeutique : traitement par les analogues de la GnRH
Bouvattier, C. M. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0521-4_9
Metadata
- Authors
- Fuqua, J. S.
- Affiliations
- Indiana University Indianapolis (US)
- Corresponding author
- Fuqua, John S.
- ORCID
- Fuqua, John S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-06-01
- Volume
- 98
- Issue
- 6
- Pages
- 2198-2207
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2170468182
- Cited by
- 260
- References
- 61
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 20 · 2023: 27 · 2022: 17 · 2021: 23 · 2020: 21 · 2019: 23 · 2018: 12 · 2017: 22 · 2016: 13 · 2015: 31 · 2014: 20 · 2013: 4
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- precocious puberty, central precocious puberty, GnRH analogues, kisspeptin, neurokinin B, dynorphin, leuprolide, familial male-limited precocious puberty, McCune-Albright syndrome, polycystic ovary syndrome, skeletal maturation, psychological outcomes, treatment outcomes
- MeSH terms
- Delayed-Action Preparations, Drug Implants, Female, Humans, Gonadotropin-Releasing Hormone, Male, Puberty, Puberty, Precocious, Leuprolide, Treatment Outcome, Kisspeptins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.